John C. Lechleiter
Chairman, President and CEO of Eli Lilly and President of IFPMA - See more at: http://www.ifpma.org/events/other-ifpma-events/view/article/innovation-and-access-online-qa-with-ifpma.html#sthash.hNgJtoMe.dpuf
John C. Lechleiter, Ph.D., has served as president and chief executive officer of Eli Lilly and Company since April 1, 2008. He became the chairman of the board of directors on January 1, 2009. He began work at Lilly in 1979 as a senior organic chemist in process research and development. Prior to joining Lilly, Lechleiter attended Xavier University (Cincinnati, Ohio), where he earned a bachelor of science degree in chemistry in 1975, and Harvard University, where he earned master’s and doctoral degrees in organic chemistry in 1980. Lechleiter has received honorary doctorates from Marian University (Indianapolis, Indiana), the University of Indianapolis, the National University of Ireland, and Indiana University. Lechleiter is a member of the American Chemical Society and Business Roundtable. He serves on the board of the Pharmaceutical Research and Manufacturers of America (PhRMA), as president of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), as chairman of the U.S.-Japan Business Council, and on the boards of United Way Worldwide, Xavier University (Cincinnati, Ohio), the Life Sciences Foundation, and the Central Indiana Corporate Partnership. He also serves on the boards of Nike, Inc. and Ford Motor Company.
2nd Apr 2014
15:00 – 16:00 UTC+01:00
IFPMA
Interviews
In this video, Andrew Jenner, IFPMA’s Executive Director, Corporate Strategy & Legal Affairs, gives the pharmaceutical industry perspective on innovation. ...
Read More
